Galmed Pharmaceuticals Embraces Market with New Sales Agreement

Galmed Pharmaceuticals (GLMD) has released an update.

Galmed Pharmaceuticals Ltd. has entered into a sales agreement with JonesTrading Institutional Services LLC, allowing the company to issue and sell ordinary shares at their discretion. This strategic move signals Galmed’s effort to leverage market opportunities and could potentially impact its stock value as shares are sold in at-the-market offerings.

For further insights into GLMD stock, check out TipRanks’ Stock Analysis page.